Is Tempus AI a Buy After a 55% Drop and 130 Day Slump?

Tempus AI Is Up From Its Lows. Can It Sustain This Recovery After a 55% Drop?

Tempus AI, Inc. (TEM) has just exited its deepest trough since its public debut, yet our data shows it remains firmly within the red zone. As of April 14, 2026, the stock has spent 137 days in a drawdown that peaked at more than half of its total market value. While the recent price action suggests a potential floor, the Drawdown Severity Score™ currently sits at 7.4, a level that historically signals significant structural recovery is still required.

Comparing this trajectory to other high growth stocks in the healthcare technology sector reveals a difficult path forward. When a stock hits a Drawdown Severity Score™ in the "Very Strong" range, it typically requires a sustained period of consolidation before a true trend reversal occurs. Our data shows that stocks entering this specific red zone often experience "false starts" where the price stabilizes but fails to reclaim the 50% retracement level of the total decline. For Tempus AI, Inc. (TEM), that level remains a distant target as the stock continues to navigate its 137-day slump.

The Current State of the TEM Drawdown

As of April 14, 2026, the current price of $45.98 represents a -55.5% drawdown from the all-time high of $103.25. This decline is significantly more severe than the average max drawdown of -28.2% recorded in the company's short trading history. While the stock has moved off its absolute lows, it remains categorized in the red zone because the Drawdown Severity Score™ of 7.4 indicates the current sell-off is still an outlier compared to its baseline volatility.

The duration of this event is also notable. At 137 days, this drawdown has lasted more than twice as long as the company’s average drawdown duration of 57 days. We have observed that when a stock exceeds its average duration by this margin, the recovery process tends to shift from a "V-shape" to a "U-shape" as institutional investors wait for fundamental confirmation before committing new capital.

How TEM Compares to Its Own History

Our data shows that Tempus AI, Inc. (TEM) has experienced 8 total historical drawdown events. Out of those 8 events, the stock has dropped by 30% or more exactly 4 times. This suggests that while a 55.5% drop is extreme, high-magnitude volatility is a recurring feature of this asset's price discovery phase.

When we look at the 4 times this has happened previously, the average duration of comparable drops was 108 days. The current 137-day stretch has already surpassed that average. It is important to note that our data for this specific ticker is based on a small sample size of 4 events: a factor investors should consider when weighing these historical averages against current market conditions.

Fundamental Catalysts and Market Sentiment

Recent news flow suggests that the fundamental narrative for Tempus AI, Inc. (TEM) is beginning to shift, even as the Drawdown Severity Score™ remains elevated. According to Investing.com, TD Cowen recently upgraded the stock rating based on stronger fundamentals. This was echoed by reports from MarketBeat, which noted the upgrade as a potential turning point for investor sentiment.

Expansion of partnerships has also provided a buffer to the selling pressure. According to Yahoo Finance, Gilead Sciences, Inc. (GILD) and Tempus AI expanded their multi-year oncology research and development collaboration. Additionally, Stock Titan reported that the company is pushing new therapy alerts as cancer care protocols change, potentially increasing the utility of its AI-driven platform. However, the market remains divided: Investing.com reports that Jefferies recently initiated coverage with an underperform rating, suggesting that valuation concerns may still weigh on the recovery.

The Road to the Green Zone

For Tempus AI, Inc. (TEM) to move out of the red zone and eventually into the green zone, it must overcome the -55.5% gap to its all-time high. In the context of our Drawdown Severity Score™, a transition out of the red zone typically requires the stock to not only increase in price but to do so with a reduction in daily volatility.

The gap between the current price of $45.98 and the all-time high of $103.25 is substantial. History shows that stocks recovering from a 50% plus drawdown often face "overhead supply" as investors who bought near the peak look to exit at break-even levels. We will continue to monitor the severity score to see if the current price stabilization is the beginning of a sustained recovery or merely a pause in a longer-term decline.